Sands Capital Management, LLC Biomarin Pharmaceutical Inc Transaction History

Sands Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$64.27 - $86.37 $358 Million - $481 Million	-5,565,620 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $11.2 Million - $14.2 Million	-166,343 Reduced 2.9%	5,565,620 $375 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $12 Million - $14 Million	-149,483 Reduced 2.54%	5,731,963 $491 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $19 Million - $22.3 Million	-226,014 Reduced 3.7%	5,881,446 $522 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $27.2 Million - $36 Million	-339,085 Reduced 5.26%	6,107,460 $520 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $45.4 Million - $51.1 Million	-483,654 Reduced 6.98%	6,446,545 $625 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $24.1 Million - $31.5 Million	-317,652 Reduced 4.38%	6,930,199 $653 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $37.2 Million - $44.4 Million	-478,927 Reduced 6.2%	7,247,851 $588 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $26.8 Million - $31.6 Million	-331,781 Reduced 4.12%	7,726,778 $689 Million
Q3 2017 Nov 14, 2017	SELL	$80.6 - $94.95 $36 Million - $42.4 Million	-446,922 Reduced 5.25%	8,058,559 $750 Million
Q2 2017 Aug 14, 2017	BUY	N/A	8,505,481	8,505,481 $772 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sands Capital Management, LLC with notifications on news.